Oral Tirzepatide GIP/GLP-1
Oral Tirzepatide is a groundbreaking dual GIP/GLP-1 receptor agonist delivered in an easy-to-take oral form. By activating both incretin pathways, it provides superior appetite suppression and metabolic improvements compared to single-target therapies. This needle-free option is ideal for patients who prefer oral dosing while still achieving significant weight loss results. Compounded in a licensed 503A pharmacy under strict quality standards.
Choose your plan:
Related Products
Compound Tirzepatide GIP/GLP-1
Injectable dual GIP/GLP-1 agonist for enhanced weight loss and metabolic health.
From $333.00/month
Compound Semaglutide GLP-1
FDA-approved GLP-1 medication for sustainable, clinically proven weight loss.
From $299.00/month
Oral Semaglutide GLP-1
Oral GLP-1 medication for needle-free weight loss with proven efficacy.
From $249.00/month
Microdose GLP-1
Low-dose GLP-1 therapy for gentle weight management and metabolic support.
From $173.00/month